§ Federal grant opportunity · RFA-RM-27-024
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
National Institutes of Health is accepting applications for Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed). The deadline is November 10, 2026 and the published award range is $50K – $100K.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- November 10, 2026
- Award range
- $50K – $100K
- Eligibility
- special district governments, nonprofits non higher education without 501c3, state governments, nonprofits non higher education with 501c3, private institutions of higher education, small businesses, county governments, independent school districts, public and state institutions of higher education, city or township governments, public and indian housing authorities, other, federally recognized native american tribal governments, other native american tribal organizations, for profit organizations other than small businesses
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-RM-27-024
Program overview
The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without evidence of disease) and create tools, models, and methods that will enable an in-depth study of its variation and composition in relation to host factors and its influence on health and disease. The purpose of this NOFO is to support small pilot projects that extend the goals of the HVP, including further validating, improving, and complementing existing and newly developed tools from the HVP program by leveraging human specimens collected from the cohorts under the program; samples from animals to promote the refinement, utilization, and translation of these tools to better serve the goals of the HVP program; expanding existing cohorts and/or biospecimen sampling sites for virome characterization; developing tools, assays, and methods to study the human virome; and defining functional interactions between the human virome and host. These pilot projects will expand the HVP consortium, and collaboration across the HVP is expected. Applicants outside the current HVP are encouraged to apply and pilot projects should not overlap with existing HVP efforts (visit the Common Fund website for a list of funded research).
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 10, 2026, allowing time for registration and validation.
Related grant opportunities
- PFE: Research Initiation in Engineering Formation (PFE: RIEF)
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
- ROSES25: C.4 Planetary Science Enabling Facilities
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.